Armistice Capital, LLC 13D and 13G filings for Mirati Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:51 pm Sale | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Armistice Capital, LLC | 500,000 0.710% | -2,988,000 (-85.67%) | Filing |
| 2023-02-14 1:10 pm Purchase | 2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Armistice Capital, LLC | 3,488,000 6.060% | 3,488,000 (New Position) | Filing |